Simulations Plus (SLP) Receives News Impact Rating of 0.18

Media stories about Simulations Plus (NASDAQ:SLP) have been trending somewhat positive recently, according to Accern. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Simulations Plus earned a coverage optimism score of 0.18 on Accern’s scale. Accern also assigned media stories about the technology company an impact score of 43.5686443725623 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Simulations Plus (NASDAQ:SLP) opened at $16.10 on Wednesday. Simulations Plus has a 12-month low of $10.10 and a 12-month high of $17.45. The company has a market cap of $283.60, a price-to-earnings ratio of 45.72 and a beta of -0.63.

Simulations Plus (NASDAQ:SLP) last posted its earnings results on Tuesday, January 9th. The technology company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.01. Simulations Plus had a net margin of 23.78% and a return on equity of 24.56%. The business had revenue of $7.07 million for the quarter, compared to analysts’ expectations of $6.57 million. research analysts anticipate that Simulations Plus will post 0.4 EPS for the current fiscal year.

SLP has been the topic of a number of recent research reports. Zacks Investment Research cut shares of Simulations Plus from a “hold” rating to a “sell” rating in a research report on Friday, December 22nd. BidaskClub raised shares of Simulations Plus from a “hold” rating to a “buy” rating in a research report on Saturday, February 24th.

In other news, CEO Walter S. Woltosz sold 18,500 shares of the business’s stock in a transaction on Wednesday, December 27th. The shares were sold at an average price of $16.25, for a total transaction of $300,625.00. Following the transaction, the chief executive officer now directly owns 5,502,416 shares of the company’s stock, valued at $89,414,260. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Over the last three months, insiders have sold 55,500 shares of company stock worth $899,655. Corporate insiders own 33.45% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Simulations Plus (SLP) Receives News Impact Rating of 0.18” was first published by Sports Perspectives and is owned by of Sports Perspectives. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at

About Simulations Plus

Simulations Plus, Inc (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour.

Insider Buying and Selling by Quarter for Simulations Plus (NASDAQ:SLP)

Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with's FREE daily email newsletter.

Leave a Reply